Association of oxidized ApoB and oxidized ApoA-I with high-risk coronary plaque features in cardiovascular disease

BACKGROUND. Oxidized apolipoprotein B (oxLDL) and oxidized ApoA-I (oxHDL) are proatherogenic. Their prognostic value for assessing high-risk plaques by coronary computed tomography angiography (CCTA) is missing.METHODS. In a prospective, observational study, 306 participants with cardiovascular dise...

Full description

Bibliographic Details
Main Authors: Alexander V. Sorokin, Christin G. Hong, Angel M. Aponte, Elizabeth M. Florida, Jingrong Tang, Nidhi Patel, Irina N. Baranova, Haiou Li, Philip M. Parel, Vicky Chen, Sierra R. Wilson, Emily L. Ongstad, Anna Collén, Martin P. Playford, Thomas L. Eggerman, Marcus Y. Chen, Kazuhiko Kotani, Alexander V. Bocharov, Alan T. Remaley
Format: Article
Language:English
Published: American Society for Clinical investigation 2023-10-01
Series:JCI Insight
Subjects:
Online Access:https://doi.org/10.1172/jci.insight.172893
_version_ 1797634191794372608
author Alexander V. Sorokin
Christin G. Hong
Angel M. Aponte
Elizabeth M. Florida
Jingrong Tang
Nidhi Patel
Irina N. Baranova
Haiou Li
Philip M. Parel
Vicky Chen
Sierra R. Wilson
Emily L. Ongstad
Anna Collén
Martin P. Playford
Thomas L. Eggerman
Marcus Y. Chen
Kazuhiko Kotani
Alexander V. Bocharov
Alan T. Remaley
author_facet Alexander V. Sorokin
Christin G. Hong
Angel M. Aponte
Elizabeth M. Florida
Jingrong Tang
Nidhi Patel
Irina N. Baranova
Haiou Li
Philip M. Parel
Vicky Chen
Sierra R. Wilson
Emily L. Ongstad
Anna Collén
Martin P. Playford
Thomas L. Eggerman
Marcus Y. Chen
Kazuhiko Kotani
Alexander V. Bocharov
Alan T. Remaley
author_sort Alexander V. Sorokin
collection DOAJ
description BACKGROUND. Oxidized apolipoprotein B (oxLDL) and oxidized ApoA-I (oxHDL) are proatherogenic. Their prognostic value for assessing high-risk plaques by coronary computed tomography angiography (CCTA) is missing.METHODS. In a prospective, observational study, 306 participants with cardiovascular disease (CVD) had extensive lipoprotein profiling. Proteomics analysis was performed on isolated oxHDL, and atherosclerotic plaque assessment was accomplished by quantitative CCTA.RESULTS. Patients were predominantly White, overweight men (58.5%) on statin therapy (43.5%). Increase in LDL-C, ApoB, small dense LDL-C (P < 0.001 for all), triglycerides (P = 0.03), and lower HDL function were observed in the high oxLDL group. High oxLDL associated with necrotic burden (NB; β = 0.20; P < 0.0001) and fibrofatty burden (FFB; β = 0.15; P = 0.001) after multivariate adjustment. Low oxHDL had a significant reverse association with these plaque characteristics. Plasma oxHDL levels better predicted NB and FFB after adjustment (OR, 2.22; 95% CI, 1.27–3.88, and OR, 2.80; 95% CI, 1.71–4.58) compared with oxLDL and HDL-C. Interestingly, oxHDL associated with fibrous burden (FB) change over 3.3 years (β = 0.535; P = 0.033) when compared with oxLDL. Combined Met136 mono-oxidation and Trp132 dioxidation of HDL showed evident association with coronary artery calcium score (r = 0.786; P < 0.001) and FB (r = 0.539; P = 0.012) in high oxHDL, whereas Met136 mono-oxidation significantly associated with vulnerable plaque in low oxHDL.CONCLUSION. Our findings suggest that the investigated oxidized lipids are associated with high-risk coronary plaque features and progression over time in patients with CVD.TRIAL REGISTRATION. ClinicalTrials.gov NCT01621594.FUNDING. National Heart, Lung, and Blood Institute at the NIH Intramural Research Program.
first_indexed 2024-03-11T12:05:17Z
format Article
id doaj.art-07ac5b93ee004406b7e818020909e4a4
institution Directory Open Access Journal
issn 2379-3708
language English
last_indexed 2024-03-11T12:05:17Z
publishDate 2023-10-01
publisher American Society for Clinical investigation
record_format Article
series JCI Insight
spelling doaj.art-07ac5b93ee004406b7e818020909e4a42023-11-07T16:26:17ZengAmerican Society for Clinical investigationJCI Insight2379-37082023-10-01820Association of oxidized ApoB and oxidized ApoA-I with high-risk coronary plaque features in cardiovascular diseaseAlexander V. SorokinChristin G. HongAngel M. AponteElizabeth M. FloridaJingrong TangNidhi PatelIrina N. BaranovaHaiou LiPhilip M. ParelVicky ChenSierra R. WilsonEmily L. OngstadAnna CollénMartin P. PlayfordThomas L. EggermanMarcus Y. ChenKazuhiko KotaniAlexander V. BocharovAlan T. RemaleyBACKGROUND. Oxidized apolipoprotein B (oxLDL) and oxidized ApoA-I (oxHDL) are proatherogenic. Their prognostic value for assessing high-risk plaques by coronary computed tomography angiography (CCTA) is missing.METHODS. In a prospective, observational study, 306 participants with cardiovascular disease (CVD) had extensive lipoprotein profiling. Proteomics analysis was performed on isolated oxHDL, and atherosclerotic plaque assessment was accomplished by quantitative CCTA.RESULTS. Patients were predominantly White, overweight men (58.5%) on statin therapy (43.5%). Increase in LDL-C, ApoB, small dense LDL-C (P < 0.001 for all), triglycerides (P = 0.03), and lower HDL function were observed in the high oxLDL group. High oxLDL associated with necrotic burden (NB; β = 0.20; P < 0.0001) and fibrofatty burden (FFB; β = 0.15; P = 0.001) after multivariate adjustment. Low oxHDL had a significant reverse association with these plaque characteristics. Plasma oxHDL levels better predicted NB and FFB after adjustment (OR, 2.22; 95% CI, 1.27–3.88, and OR, 2.80; 95% CI, 1.71–4.58) compared with oxLDL and HDL-C. Interestingly, oxHDL associated with fibrous burden (FB) change over 3.3 years (β = 0.535; P = 0.033) when compared with oxLDL. Combined Met136 mono-oxidation and Trp132 dioxidation of HDL showed evident association with coronary artery calcium score (r = 0.786; P < 0.001) and FB (r = 0.539; P = 0.012) in high oxHDL, whereas Met136 mono-oxidation significantly associated with vulnerable plaque in low oxHDL.CONCLUSION. Our findings suggest that the investigated oxidized lipids are associated with high-risk coronary plaque features and progression over time in patients with CVD.TRIAL REGISTRATION. ClinicalTrials.gov NCT01621594.FUNDING. National Heart, Lung, and Blood Institute at the NIH Intramural Research Program.https://doi.org/10.1172/jci.insight.172893CardiologyInflammation
spellingShingle Alexander V. Sorokin
Christin G. Hong
Angel M. Aponte
Elizabeth M. Florida
Jingrong Tang
Nidhi Patel
Irina N. Baranova
Haiou Li
Philip M. Parel
Vicky Chen
Sierra R. Wilson
Emily L. Ongstad
Anna Collén
Martin P. Playford
Thomas L. Eggerman
Marcus Y. Chen
Kazuhiko Kotani
Alexander V. Bocharov
Alan T. Remaley
Association of oxidized ApoB and oxidized ApoA-I with high-risk coronary plaque features in cardiovascular disease
JCI Insight
Cardiology
Inflammation
title Association of oxidized ApoB and oxidized ApoA-I with high-risk coronary plaque features in cardiovascular disease
title_full Association of oxidized ApoB and oxidized ApoA-I with high-risk coronary plaque features in cardiovascular disease
title_fullStr Association of oxidized ApoB and oxidized ApoA-I with high-risk coronary plaque features in cardiovascular disease
title_full_unstemmed Association of oxidized ApoB and oxidized ApoA-I with high-risk coronary plaque features in cardiovascular disease
title_short Association of oxidized ApoB and oxidized ApoA-I with high-risk coronary plaque features in cardiovascular disease
title_sort association of oxidized apob and oxidized apoa i with high risk coronary plaque features in cardiovascular disease
topic Cardiology
Inflammation
url https://doi.org/10.1172/jci.insight.172893
work_keys_str_mv AT alexandervsorokin associationofoxidizedapobandoxidizedapoaiwithhighriskcoronaryplaquefeaturesincardiovasculardisease
AT christinghong associationofoxidizedapobandoxidizedapoaiwithhighriskcoronaryplaquefeaturesincardiovasculardisease
AT angelmaponte associationofoxidizedapobandoxidizedapoaiwithhighriskcoronaryplaquefeaturesincardiovasculardisease
AT elizabethmflorida associationofoxidizedapobandoxidizedapoaiwithhighriskcoronaryplaquefeaturesincardiovasculardisease
AT jingrongtang associationofoxidizedapobandoxidizedapoaiwithhighriskcoronaryplaquefeaturesincardiovasculardisease
AT nidhipatel associationofoxidizedapobandoxidizedapoaiwithhighriskcoronaryplaquefeaturesincardiovasculardisease
AT irinanbaranova associationofoxidizedapobandoxidizedapoaiwithhighriskcoronaryplaquefeaturesincardiovasculardisease
AT haiouli associationofoxidizedapobandoxidizedapoaiwithhighriskcoronaryplaquefeaturesincardiovasculardisease
AT philipmparel associationofoxidizedapobandoxidizedapoaiwithhighriskcoronaryplaquefeaturesincardiovasculardisease
AT vickychen associationofoxidizedapobandoxidizedapoaiwithhighriskcoronaryplaquefeaturesincardiovasculardisease
AT sierrarwilson associationofoxidizedapobandoxidizedapoaiwithhighriskcoronaryplaquefeaturesincardiovasculardisease
AT emilylongstad associationofoxidizedapobandoxidizedapoaiwithhighriskcoronaryplaquefeaturesincardiovasculardisease
AT annacollen associationofoxidizedapobandoxidizedapoaiwithhighriskcoronaryplaquefeaturesincardiovasculardisease
AT martinpplayford associationofoxidizedapobandoxidizedapoaiwithhighriskcoronaryplaquefeaturesincardiovasculardisease
AT thomasleggerman associationofoxidizedapobandoxidizedapoaiwithhighriskcoronaryplaquefeaturesincardiovasculardisease
AT marcusychen associationofoxidizedapobandoxidizedapoaiwithhighriskcoronaryplaquefeaturesincardiovasculardisease
AT kazuhikokotani associationofoxidizedapobandoxidizedapoaiwithhighriskcoronaryplaquefeaturesincardiovasculardisease
AT alexandervbocharov associationofoxidizedapobandoxidizedapoaiwithhighriskcoronaryplaquefeaturesincardiovasculardisease
AT alantremaley associationofoxidizedapobandoxidizedapoaiwithhighriskcoronaryplaquefeaturesincardiovasculardisease